surpass 1 tirzepatide SURMOUNT-1 Trial Tirzepatide: A Novel, Once-weekly Dual

doi: 10.1158/1078-0432.CCR-12-1067

The combination of prednisone and GLP-1 therapy can actually provide a clinical advantage: GLP-1 medications help mitigate steroid-induced hyperglycemia and appetite surge

Patients receiving tesamorelin saw visceral fat drop by 15.2%, while the placebo groups visceral fat actually increased by 5%

WangTMaJZhangQGaoAWangQLiHet alExpanded newborn screening for inborn errors of metabolism by tandem mass spectrometry in Suzhou, China: disease spectrum, prevalence, genetic characteristics in a Chinese population

PlexusDx supplies compounded options such as Semaglutide Injection through licensed pathways

Associate Editor Eli Lilly and Company has announced the availability of Zepbound (tirzepatide) 2.5 mg and 5 mg single-dose vials for self-pay patients with an on-label prescription